痴呆症护理研究和心理社会因素
Kajal Kajal1, Smriti Thakur2, Rahul Renukadas Deshmukh3
1Central University of Punjab, Bathinda, Punjab, India.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
芬戈利莫德 (FTY720) 在大鼠中表现出神经保护作用,对抗胆固醇诱导的痴呆症. 这项阿尔茨海默氏症研究表明,FTY720减少了认知衰退和氧化应激,保持了大脑结构.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学 是一个学科.
- 生物化学 生物化学
背景情况:
- 阿尔茨海默病 (AD) 涉及认知能力下降,粉样β斑块和团.
- 脂质代谢失调,氧化应激和神经炎症是AD的关键因素.
- 实验模型对于理解AD病理生理学和测试治疗方法至关重要.
研究的目的:
- 为了研究Fingolimod (FTY720) 在偶发性痴呆症小鼠模型中的神经保护潜力.
- 评估Fingolimod对认知功能,氧化应激和神经元完整性的影响.
主要方法:
- 在小鼠中使用脑内内胆固醇 (ICV-COL) 诱导的实验性痴呆症.
- 在交替的日子里服用Fingolimod (0.25和0.5毫克/公斤).
- 使用莫里斯水迷宫和物体识别测试评估空间和非空间记忆.
- 在海马体和皮质中测量了氧化应激标志物 (甲,减少的谷氨,催化酶).
- 通过组织病理学检查评估神经退行.
主要成果:
- 输入ICV-COL诱导了显著的认知缺陷和增加了氧化应激标志物.
- 芬戈利莫德治疗减轻了素诱导的认知衰退.
- 芬戈利莫德降低了氧化负担,并保留了海马和皮质中的神经元结构.
- 组织病理学检查证实了Fingolimod治疗大鼠的神经退行减少.
结论:
- 芬戈利莫德对ICV-COL诱导的痴呆症具有显著的神经保护潜力.
- 在这个模型中,FTY720有效地减轻了认知缺陷和氧化应激.
- 芬戈利莫德在治疗像阿尔茨海默氏症这样的认知障碍方面具有前景.
更多相关视频
08:36The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
4.3K
10:13Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
14.1K
相关概念视频
Dementia
482
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
482
Psychological and Sociocultural Causes of Schizophrenia
438
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
438
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment
744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744
Cognitive Development During Adulthood
740
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
740
Documentation in Long-Term and Home Healthcare Setting
1.4K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.4K
